Effects of integrase inhibitor-based antiretroviral therapy on brain outcomes according to time since acquisition of HIV-1 infection

Triumeq Increases Excitability of Pyramidal Neurons in the Medial Prefrontal Cortex by Facilitating Voltage-Gated Ca2+ Channel Function

(2021) Lihua Chen et al.   Frontiers in Pharmacology

Very early ART initiation during acute HIV infection is associated with normalization of cerebrospinal fluid but not plasma markers of immune activation

(2019) Joanna Hellmuth et al.   JOURNAL OF INFECTIOUS DISEASES

Neuropsychiatric Adverse Events with Dolutegravir and Other Integrase Strand Transfer Inhibitors

(2019) Christian Hoffmann et al.   AIDS REVIEWS

Altered neuropsychological performance and reduced brain volumetrics in people living with HIV on integrase strand transfer inhibitors

(2019) Jane A. O’Halloran et al.   AIDS

Antiretroviral-Mediated Microglial Activation Involves Dysregulated Autophagy and Lysosomal Dysfunction

(2019) Ashutosh Tripathi et al.   Cells

Considerations on nosology for HIV-associated neurocognitive disorders: it is time to update?

(2019) Nicoletta Ciccarelli   INFECTION

Longitudinal Trajectories of Brain Volume and Cortical Thickness in Treated and Untreated Primary Human Immunodeficiency Virus Infection

(2018) Ryan Sanford et al.   CLINICAL INFECTIOUS DISEASES

Association of Brain Structure Changes and Cognitive Function With Combination Antiretroviral Therapy in HIV-Positive Individuals

(2018) Ryan Sanford et al.   JAMA Neurology

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults

(2018) Michael S. Saag et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Regionally Specific Brain Volumetric and Cortical Thickness Changes in HIV-Infected Patients in the HAART Era

(2017) Ryan Sanford et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Early Antiretroviral Therapy Is Associated with Lower HIV DNA Molecular Diversity and Lower Inflammation in Cerebrospinal Fluid but Does Not Prevent the Establishment of Compartmentalized HIV DNA Populations

(2017) Michelli F. Oliveira et al.   PLoS Pathogens

Transdermal rivastigmine for HIV-associated cognitive impairment: A randomized pilot study

(2017) Jose A. Muñoz-Moreno et al.   PLoS One

Topographies of Cortical and Subcortical Volume Loss in HIV and Aging in the cART Era

(2016) Anika Guha et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Cortical brain atrophy and intra-individual variability in neuropsychological test performance in HIV disease

(2015) Lindsay J. Hines et al.   Brain Imaging and Behavior

Neuropsychological Impairment in Acute HIV and the Effect of Immediate Antiretroviral Therapy

(2015) Idil Kore et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study

(2015) Ned Sacktor et al.   NEUROLOGY

Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection

(2014) A. C. Young et al.   NEUROLOGY

Low prevalence of neurocognitive impairment in early diagnosed and managed HIV-infected persons

(2013) N. F. Crum-Cianflone et al.   NEUROLOGY

HIV and Neurocognitive Dysfunction

(2013) Serena Spudich   Current HIV/AIDS Reports

Symmetric diffeomorphic modeling of longitudinal structural MRI

(2013) John Ashburner   Frontiers in Neuroscience

Change in Brain Magnetic Resonance Spectroscopy after Treatment during Acute HIV Infection

(2012) Napapon Sailasuta et al.   PLoS One

The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?

(2011) Magnus Gisslén et al.   BMC INFECTIOUS DISEASES

Subcortical brain atrophy persists even in HAART-regulated HIV disease

(2011) James T. Becker et al.   Brain Imaging and Behavior

Regional Cortical Thinning Associated with Detectable Levels of HIV DNA

(2011) K. J. Kallianpur et al.   CEREBRAL CORTEX

Neurocognitive functioning in acute or early HIV infection

(2010) David J. Moore et al.   JOURNAL OF NEUROVIROLOGY

Does highly active antiretroviral therapy improve neurocognitive function? A systematic review

(2010) John A Joska et al.   JOURNAL OF NEUROVIROLOGY

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

(2010) R. K. Heaton et al.   NEUROLOGY